High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.

Abstract excerpt

Antibiotic-resistant infections kill approximately 23,000 people and cost $20,000,000,000 each year in the United States alone despite the widespread use of small-molecule antimicrobial combination therapy. Antibiotic combinations typically have an additive effect: the efficacy of the combination matches the sum of the efficacies of each antibiotic when used alone. Small molecules can also act synergistically...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biological Assay
• Share to Drug Synergism